Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II clinical trial (RCT), offering an early signal that could reshape how advanced ...
Virta Health, the leader in reversing metabolic disease, announced today results from a randomized, controlled Phase II ...
GlobalData on MSN
Virta Health reports improved outcomes in pancreatic cancer trial
The trial enrolled patients who received a triplet chemotherapy regimen of nab-paclitaxel, cisplatin, and gemcitabine.
Detailed price information for Henry Schein Inc (HSIC-Q) from The Globe and Mail including charting and trades.
Objective Biologics for systemic lupus erythematosus (SLE) demonstrate variable treatment responses across trials. We evaluated baseline biomarkers as predictors of response to guide personalised ...
RedCloud Holdings plc (NASDAQ: RCT) ("RedCloud" or the "Company"), the technology company building AI infrastructure for global trade, today announced the appointment of Raju Datla as Chief Financial ...
This week's biotech landscape witnessed key FDA approvals, EU approvals, IND clearances, acquisitions, and clinical trial data readouts across key therapeutic areas such ...
ASIC is on the hunt for companies which haven’t filed financial reports, and corporate experts said the rich lister’s sprawling empire could be in its sights. The ACCC will not block Hong Kong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results